| Media News by Date |
| |
| August 2009 |
| FDA Accepts Drug Application For Miconazole Lauriad(R) To Treat Oropharyngeal Candidiasis (OPC). OPC, familiarly known as thrush, is an oral fungal infection that results in lesions and inflammation in the mouth, and includes symptoms such as soreness, burning and/or altered taste most common in individuals with weakened immune systems. Upon FDA approval, this would be the first oral miconazole therapy available in the U.S. Medical News Today. 08/20/09. (Also see: Candida) |
| FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs. The U.S. Food and Drug Administration published two rules today that seek to clarify the methods available to seriously ill patients interested in gaining access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and don’t have other satisfactory treatment options. U.S. Food and Drug Administration. 08/12/09. (Also see: Medications) |
| Treatment For Chronic Illness Must Be Less Disruptive In The Daily Lives Of Patients. Professors Carl May, Victor Montori, and Frances Mair write: "Chronic disease is the great epidemic of our times, but the strategies we have developed to manage it have created a growing burden for patients". This treatment burden leads to poor observance, wasted resources, and poor results. Medical News Today. 08/12/09. (Also see: Coping) |
| Osteoporosis drugs effective in killing flu viruses. Two existing drugs used to treat osteoporosis may be effective in killing influenza viruses, including the new H1N1 swine flu and the H5N1 bird flu viruses, researchers in Hong Kong have found. Reuters. 08/14/09. (Also see: Osteoporosis) |
| Does A Cup Of Tea Reduce Stress? Several daily newspapers in the UK and elsewhere carry reports this week of a study commissioned by the Direct Line insurance company that suggests a cup of tea reduces stress, not just by drinking it but also because of the calming effect of the ritual of putting the kettle on. Medical News Today. 8/14/09. (Also see: Stress and Coping) |
| Ultraviolet light can aid treatment of vitiligo. Vitiligo patients will notice that areas of skin have lost their pigment, and this may be preceded by itching or irritation. Narrow band ultraviolet B seems to be beneficial for the treatment of vitiligo. Shari Rudavsky. IndyStar.com. 08/13/09. (Also see: Vitiligo) |
| PH Patients and Family Education Forum. This page provides an index of information on PH ranging from exercise to diet, testing and treatments. A wealth of information for anyone with PAH. Pulmonary Hypertension Association. (Also see: PAH) |
| Pessimism, Cynicism Can Hurt Your Heart Study: Negative Outlook Appears to Raise Risk of Heart Disease, Death. Whether you believe the metaphorical glass is half full or half empty may not only affect how you see the world, it may also affect your heart. Salynn Boyles WebMD Health News. 08/100/09. (Also see: Emotional Adjustment) |
| Study: Doctors Don't Always Spot Depression. In a review of 41 previous studies involving more than 50,000 patients in developed nations around the world, the authors found that general practitioners make frequent mistakes, missing true cases of depression about half the time, and incorrectly diagnosing it in 19% of healthy people. John Cloud (Time). Yahoo News. 07/30/09. (Also see: Depression) |
| Alternative medicine a big business in U.S.: report. Complementary and alternative medicine such as acupuncture, herbal supplements and meditation are big business in the USA, totaling nearly $34 billion in out-of-pocket spending, according to a government report released on Thursday. With so many Americans using and spending money on (complementary and alternative) therapies, it is extremely important to know whether the products and practices they use are safe and effective. Reuters. Jul 30, 2009. (Also see: Alternative Therapies) |
| Arthritis drugs raise cancer risk in kids-US FDA. The Food and Drug Administration, which urged greater caution with so-called TNF blockers last September, said an analysis of 48 reported cancer cases in children using the drugs "showed an increased risk of cancer, occurring after 30 months of treatment on average." Reuters. 08/04/09. (Also see: TNF Inhibitors and FDA Warnings) |
| Lupus Drugs Dull Flu Shots. Immunity-suppressing lupus drugs dampen the effects of flu vaccines, a Dutch study warns. Lupus patients who are taking these drugs at the same time they get their flu shots may be vulnerable to flu complications.Daniel J. DeNoon. WebMD. 07/30/09. (Also see: Vaccinations) |
| Flu Vaccine Panel Creates Priority List. The top-priority group includes about 160 million people and contains five populations: pregnant women; household contacts of children younger than 6 months; health-care and emergency medical services workers; everyone 6 months to 24 years old; and people 25 to 64 who have conditions that put them at higher risk of serious infection and death. David Brown Washington Post Staff Writer Thursday, July 30, 2009. (Also see: Vaccinations) |
| Sun Exposure May Trigger Certain Autoimmune Diseases in Women. This study found that women who lived in areas with higher levels of UV exposure when they developed an autoimmune muscle disease called myositis were more likely to develop the form known as dermatomyositis, which weakens the muscles and causes distinctive rashes, instead of the form called polymyositis that does not have a rash. NIH News. 07/30/09. (Also see: Dermatomyositis) |
| Safe Sun Protection. For people with specific autoimmune disorders, protection from the sun should be a serious perennial consideration. Conditions such as Lupus, dermatomyositis, scleroderma and vitaligo are autoimmune diseases that are sun-sensitive. Mary Jo DiLonardo. Arthritis Today. July 2009. (Also see: Sunshine and Scleroderma) |
| Pennsylvania man with rare disease needs new lungs. Kiner, 46, has learned to live with scleroderma, a rare, chronic autoimmune disease characterized by a hardening of the skin and, in his case, his lungs. Doctors have told him that he needs a double-lung transplant to survive. Rebecca Barnett. The Patriot-News. July 27, 2009. |
| FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension (PAH). In the TRIUMPH-1 randomized, double-blind, 12-week placebo-controlled clinical trial, patients taking TYVASO in four daily inhalation sessions achieved a 20-meter improvement in six-minute walk distance over those taking placebo. United Therapeutics plans to launch TYVASO in conjunction with its wholly-owned subsidiary, Lung Rx, Inc., in the United States at the beginning of September 2009. PR Newswire. 07/31/09. (Also see: PAH) |
Hello, I am